3-[2-Aminomethyl]-N-Methyl-1H-Indole-5-Methane Sulfonamide

88919-22-6

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprisπe that is market-oriented and realizes industrial development through R&D innovation and £technology transformation.

key word:

technology innovative

Category:

Consulting
Related

Product Description

Integrity, innovation, cooperation, sharing, win-win

The company integrates multiple resources and strives to build a large health industry finance♦ platform company integrating pharmaceutical, intelligent medical, bio pharmaceutical R&D,  industrial production and sales.

The chemical reactions involved in the existing products inclu₩de Foucault reaction, nitration reaction, sulfonation reaction, hydrogenation reaction, flu orination reaction, chlorination reaction, bromination reaction¥, diazotization reaction, format reaction, etc.

Related products

Sitagliptin Phosphate Monohydrate

Sitagliptin phosphate is a dipeptidyl peptidase-4 (DPP4) inhibitor developed by Merck. I™n October 2006, Sitagliptin phosphate Januvia was apλproved by FDA as the first DPP4 inhibitor for the treatment of type ⅱ diabetes mellitus. T≤he characteristics of this drug are that it can stimulate insulin secretion while reducing hunger &without causing weight gain. Hypoglycemia and edema will not occur, and it is suitable for d​iabetic patients with poor blood glucose control an d frequent hypoglycemia.

Sumatriptan Succinate

Medication for migraine

Vildagliptin

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-¥oriented and realizes industrial development through R&D innovation and techno↓logy transformation.

Ketoprofen

The non-steroidal anti-inflammatory drug ketoprofen is one of the most import₽ant products for the treatment of arthritis. It is well tol​erated and has a low incidence of side effects

Pranlukast

Pranlukast, developed by Ono, is one of the three major leukotriene receptor an←tagonists. In clinical application, it has good theαrapeutic effect on atopic asthma and other types of bronchial asthma, and the market prospect i×s huge. In the major category of asthma drugs, leukotriene receptoγr antagonists have the fastest growing market share.

Avanafil

Chenglian Pharmaceutical is an innovative high-tech p₽harmaceutical enterprise that is market-oriented and realizes industrial development✘ through R&D innovation and technology transformation.

Donepezil HCL

Treatment of mild to moderate Alzheimer's syndrome. It is the♦ second drug approved by FDA for Alzheimer's diseaΩse in the United States. Its treatment reaches the target ‌dose and has low toxic and side effects. It has been widely recognized♦ by our medical community, and good tolerance is its bigge st advantage. In October 1999, Donepezil was launched in China under the× trade name "Aricept", which is the main chemical drug against Alzheimer's dis↑ease. At present, CFDA has approved a number of domestic enterprises to produce ≥donepezil preparations, the main dosage forms are tablets, capsules, dispersive tablets, oral disi​ntegrating tablets.

Almotriptan

Migraine medication for adolescents

Apixaban

English name Apixaban Trade name ELIQUIS, tablet: Apixaban (Eliλquis, Bristol-Myers Squibb/Pfizer), a direct oral factor Xa ★inhibitor, was approved for use in the 27 EU membe↔r states. The world's first drug approved to prevent venous thr¶omboembolism (VTE) in adult patients undergoing elective hip or knee replacement. From June 2019 t‌o June 2020, the annual sales of apixaban products overseas★ reached about $15.4 billion, with a year-on-year growth of  nearly 32%, and the API consumption reached about 23,960 kg, w↕ith a year-on-year growth of about 28%. Compared with its main competitor, R‌ivaroxaban, the drug's annual overseas sales are about $4.5 <billion higher.

Lenvatinib

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that is market-orient✔ed and realizes industrial development through R&D innovat‍ion and technology transformation.

Clofarabine

It is a nucleotide analogue developed by Bioenvision and manufactured by₽ Genzyme. On December 29, 2004, it was approved by FDA for the treatment o✔f refractory or relapsed acute lymphoblastic leukemia (ALL) in childre☆n.

Upadacitinib(Scientific research)

Chenglian Pharmaceutical is an innovative high-tech pharmaceutical enterprise that​ is market-oriented and realizes industrial development through γR&D innovation and technology transformation.

Product Consulting

Our staff will contact you within 24 hours (working days). If ¶you need other services, E-mail: 2880705932@qq.com